These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2869019)

  • 21. Affinity chromatography of glycopeptide antibiotics.
    Folena-Wasserman G; Sitrin RD; Chapin F; Snader KM
    J Chromatogr; 1987 Apr; 392():225-38. PubMed ID: 3597575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helvecardins A and B, novel glycopeptide antibiotics. III. Biological properties.
    Takeuchi M; Katayama T; Inukai M
    J Antibiot (Tokyo); 1991 Mar; 44(3):278-81. PubMed ID: 2026552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility to erythromycin of anaerobes of the genera Bacteroides, Fusobacterium, Sphaerophorus, Veillonella, Clostridium, Corynebacterium, Peptococcus, Peptostreptococcus.
    Werner H; Boehm M; Kunstek-Santos H; Lohner C; Jordan T
    Arzneimittelforschung; 1977; 27(12):2263-5. PubMed ID: 580038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
    Arhin FF; Belley A; McKay GA; Moeck G
    Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of Sch 34343 against nosocomial pathogens: methicillin-resistant staphylococci, gentamicin-susceptible and -resistant Streptococcus faecalis, Clostridium difficile and Bacteroides fragilis.
    Kurpis L; Schaberg D; Fekety R
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():133-6. PubMed ID: 3928577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
    He H
    Appl Microbiol Biotechnol; 2005 Jun; 67(4):444-52. PubMed ID: 15702316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
    Wootton M; Walsh TR; Davies EM; Howe RA
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):226-32. PubMed ID: 19199533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility of Clostridium perfringens type A to 23 antimicrobial drugs.
    Traub WH; Karthein J; Spohr M
    Chemotherapy; 1986; 32(5):439-45. PubMed ID: 2875853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.
    Hassan H; O'Hare MD; Felmingham D
    Singapore Med J; 1990 Feb; 31(1):56-8. PubMed ID: 2139737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the sensitivity to antibiotics of Bacteroides and Fusobacterium using the ATB ANA system].
    Monteil H; Rasoamananjara D; Vetter MT
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):648-52. PubMed ID: 3534761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibacterial activity of lividomycin against anaerobes].
    Ninomiya K; Kamiya H; Ueno K; Suzuki S; Ryu J
    Jpn J Antibiot; 1972 Dec; 25(6):356-9. PubMed ID: 4353340
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methods of determining the sensitivity of anaerobic bacteria to antibacterial drugs].
    Ponomareva TR; Dronova OM; Smolianskaia AZ
    Antibiotiki; 1984 Dec; 29(12):931-9. PubMed ID: 6395798
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of chloropolysporin-C, a new glycopeptide-group antibiotic, on Clostridium perfringens isolates and its in vivo activity against C perfringens and other intestinal microflora of the caeca of broiler chickens.
    Kondo F; Tateyama S
    Res Vet Sci; 1990 Mar; 48(2):175-9. PubMed ID: 2333425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.